Table 3.
Predictor | Estimated adjusted OR | |||
---|---|---|---|---|
OR | 95% CI | P | ||
Age: ≥65 vs. <65 yearsa | 1.108 | 0.248 | 4.948 | 0.893 |
Educational level: ≤ high school vs. ≥college | 0.213 | 0.053 | 0.858 | 0.030 |
Employment: Unemployed vs. employed | 0.466 | 0.133 | 1.639 | 0.234 |
Metastasis: Yes vs. no | 0.319 | 0.018 | 5.784 | 0.440 |
Total dose of taxane anticancer agents | 1.000 | 1.000 | 1.001 | 0.211 |
NCI-CTCAE version 4.0 grade: ≥2 vs. 1 | 6.415 | 1.271 | 32.379 | 0.024 |
Total score of FACT/GOG-NTX | 0.874 | 0.808 | 0.946 | 0.001 |
a≥65 years=0, <65 years=1. NCI-CTCAE: National Cancer Institute Common Terminology Criteria for Adverse Events, FACT/GOG-NTX: Functional Assessment of Cancer Therapy-Gynecologic Oncology Group-Neurotoxicity, OR: Odds ratio, CI: Confidence interval